Back to Search
RYAN KATES, PHARMD
PHARMD
Infectious Diseases Pharmacist
NPI: 1801600069Individual
Specialties, Licenses & Credentials
Infectious Diseases PharmacistPrimary
Pharmacist — Infectious Diseases
Code: 1835I0206X
051298236(IL)
Research & Publications (20)
Side-effects of pre-operative epirubicin-paclitaxel therapy in primary breast cancer associated with tumor biology.
PMID 19596945·Anticancer Res·2009
8-other
Optimized pro-active management of anemia by Epoetin alpha in pre-operative chemotherapy for primary breast cancer.
PMID 19212639·Oncol Rep·2009
3-trial
Postoperative sense of well-being and quality of life in breast cancer patients do not depend on type of primary surgery.
PMID 18322412·Onkologie·2008
8-other
Triple-negative high-risk breast cancer derives particular benefit from dose intensification of adjuvant chemotherapy: results of WSG AM-01 trial.
PMID 18174609·Ann Oncol·2008
4-observational
African poverty: a grand challenge for sustainability science.
PMID 17942667·Proc Natl Acad Sci U S A·2007
8-other
Improvement of safety profile of docetaxel by weekly administration in patients with metastatic breast cancer.
PMID 17848815·Onkologie·2007
8-other
DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients--Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group.
PMID 17601725·Eur J Cancer·2007
4-observational
Tumor-associated proteolytic factors uPA and PAI-1: critical appraisal of their clinical relevance in breast cancer and their integration into decision-support algorithms.
PMID 17364692·Crit Rev Clin Lab Sci·2007
6-review
Primary tumor levels of human tissue kallikreins affect surgical success and survival in ovarian cancer patients.
PMID 17363527·Clin Cancer Res·2007
8-other
Analysis of specific transcriptional regulators as early predictors of independent prognostic relevance in resected colorectal cancer.
PMID 17317820·Clin Cancer Res·2007
8-other
Reconstruction of New Orleans after Hurricane Katrina: a research perspective.
PMID 17003119·Proc Natl Acad Sci U S A·2006
8-other
Intraoperative assessment of mitral regurgitation: role of phenylephrine challenge.
PMID 16950471·J Am Soc Echocardiogr·2006
2-rct
Disease processes may be reflected by correlations among tissue kallikrein proteases but not with proteolytic factors uPA and PAI-1 in primary ovarian carcinoma.
PMID 16895483·Biol Chem·2006
8-other
FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer.
PMID 16822847·J Clin Oncol·2006
8-other
Analysis of the DPYD gene implicated in 5-fluorouracil catabolism in a cohort of Caucasian individuals.
PMID 16115930·Clin Cancer Res·2005
4-observational
Urokinase-type plasminogen activator and its inhibitor type 1 predict disease outcome and therapy response in primary breast cancer.
PMID 15585071·Clin Breast Cancer·2004
6-review
Urokinase-type plasminogen activator (uPA) and its inhibitor PAI-I: novel tumor-derived factors with a high prognostic and predictive impact in breast cancer.
PMID 14983219·Thromb Haemost·2004
6-review
Is it necessary to obtain serum levels of thyroid stimulating hormone and prolactin in asymptomatic women with infertility?
PMID 14502861·Conn Med·2003
8-other
Pooled analysis of prognostic impact of uPA and PAI-1 in breast cancer patients.
PMID 12958624·Thromb Haemost·2003
8-other
Long-term trends and a sustainability transition.
PMID 12829798·Proc Natl Acad Sci U S A·2003
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1422 W IRVING PARK RD APT 3
CHICAGO, IL 60613 - Phone
- (224) 519-3347
Quick Facts
- NPI
- 1801600069
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile